Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights.
Martin JE, Khalife-Hachem S, Grinda T, Kfoury M, Garciaz S, Pasquier F, Vargaftig J, Uzunov M, Belhabri A, Bertoli S, Cotteret S, Vergé V, Renneville A, Rosselli F, Antony-Debre I, Rouleau E, Salviat F, Caron O, Delaloge S, Pautier P, Etienne G, Recher C, Vey N, De Botton S, Leary A, Marzac C, Micol JB. Martin JE, et al. Among authors: marzac c. Ann Oncol. 2021 Aug;32(8):1046-1048. doi: 10.1016/j.annonc.2021.04.015. Epub 2021 Jun 6. Ann Oncol. 2021. PMID: 34107346 Free article. No abstract available.
Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.
Sakr R, Renneville A, Saada V, Cotteret S, Martin JE, Droin N, Selimoglu-Buet D, Besse B, Hollebecque A, Marzac C, Pasquier F, Micol JB, De Botton S, Mir O, Solary E, Willekens C. Sakr R, et al. Among authors: marzac c. Leuk Lymphoma. 2018 Jul;59(7):1742-1745. doi: 10.1080/10428194.2017.1397669. Epub 2017 Nov 8. Leuk Lymphoma. 2018. PMID: 29115897 No abstract available.
Germline RUNX1 Intragenic Deletion: Implications for Accurate Diagnosis of FPD/AML.
Duployez N, Martin JE, Khalife-Hachem S, Benkhelil R, Saada V, Marzac C, Auger N, Marceau-Renaut A, Favier R, Ballerini P, Caron O, Baruchel A, de Botton S, Preudhomme C, Micol JB, Raslova H, Antony-Debré I. Duployez N, et al. Among authors: marzac c. Hemasphere. 2019 Jun 4;3(3):e203. doi: 10.1097/HS9.0000000000000203. eCollection 2019 Jun. Hemasphere. 2019. PMID: 31723833 Free PMC article. No abstract available.
Spontaneous molecular response of IDH2 acute myeloid leukemia.
Khalife-Hachem S, Pegliasco J, Saada V, Hernandez E, Camara-Clayette V, Cotteret S, Benabdelali R, de Botton S, Marzac C, Micol JB. Khalife-Hachem S, et al. Among authors: marzac c. Ann Hematol. 2020 Feb;99(2):353-354. doi: 10.1007/s00277-019-03876-8. Epub 2019 Dec 9. Ann Hematol. 2020. PMID: 31814054 No abstract available.
ATG2B/GSKIP in de novo acute myeloid leukemia (AML): high prevalence of germline predisposition in French West Indies.
Pegliasco J, Schmaltz-Panneau B, Martin JE, Chraibi S, Khalife-Hachem S, Salviat F, Pasquier F, Willekens C, Lopez M, Ben-Ali A, Bera O, Caron O, Castilla-Llorent C, Cotteret S, Bourdin C, Saada V, Auger N, de Botton S, Vainchenker W, Fuseau P, Helias P, Benabdelali R, Marzac C, Meniane JC, Plo I, Bellanné-Chantelot C, Micol JB. Pegliasco J, et al. Among authors: marzac c. Leuk Lymphoma. 2021 Jul;62(7):1770-1773. doi: 10.1080/10428194.2021.1881508. Epub 2021 Feb 7. Leuk Lymphoma. 2021. PMID: 33554699 No abstract available.
Plasma cell dedifferentiation in refractory multiple myeloma.
Arbab A, Saada V, Cotteret S, Marzac C, Ghez D. Arbab A, et al. Among authors: marzac c. Br J Haematol. 2021 Apr;193(2):212. doi: 10.1111/bjh.17244. Epub 2021 Mar 26. Br J Haematol. 2021. PMID: 33772753 No abstract available.
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies.
Renneville A, Gasser JA, Grinshpun DE, Jean Beltran PM, Udeshi ND, Matyskiela ME, Clayton T, McConkey M, Viswanathan K, Tepper A, Guirguis AA, Sellar RS, Cotteret S, Marzac C, Saada V, De Botton S, Kiladjian JJ, Cayuela JM, Rolfe M, Chamberlain PP, Carr SA, Ebert BL. Renneville A, et al. Among authors: marzac c. Blood Cancer Discov. 2021 May;2(3):250-265. doi: 10.1158/2643-3230.BCD-20-0105. Epub 2021 Mar 10. Blood Cancer Discov. 2021. PMID: 34027417 Free PMC article.
Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms.
Pegliasco J, Hirsch P, Marzac C, Isnard F, Meniane JC, Deswarte C, Pellet P, Lemaitre C, Leroy G, Rabadan Moraes G, Guermouche H, Schmaltz-Panneau B, Pasquier F, Colas C, Benusiglio PR, Bera O, Bourhis JH, Brissot E, Caron O, Chraibi S, Cony-Makhoul P, Delaunay-Darivon C, Lapusan S, de Fontbrune FS, Fuseau P, Najman A, Vainchenker W, Delhommeau F, Micol JB, Plo I, Bellanné-Chantelot C. Pegliasco J, et al. Among authors: marzac c. Leukemia. 2022 Jan;36(1):126-137. doi: 10.1038/s41375-021-01319-w. Epub 2021 Jun 25. Leukemia. 2022. PMID: 34172895
Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers.
Khalife-Hachem S, Saleh K, Pasquier F, Willekens C, Tarabay A, Antoun L, Grinda T, Castilla-Llorente C, Duchmann M, Quivoron C, Auger N, Saada V, Delaloge S, Leary A, Renneville A, Antony-Debre I, Rosselli F, De Botton S, Salviat F, Marzac C, Micol JB. Khalife-Hachem S, et al. Among authors: marzac c. Hemasphere. 2021 Aug 18;5(9):e632. doi: 10.1097/HS9.0000000000000632. eCollection 2021 Sep. Hemasphere. 2021. PMID: 34423258 Free PMC article.
76 results